Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gunter Schuch

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Leukemia & Lymphoma|December 16, 2006
Downregulation of VEGF-A, STAT5 and AKT in acute myeloid leukemia blasts of patients treated with SU5416Sonja Loges, Heike Tinnefeld, Anja Metzner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2008
Fluorouracil, leucovorin, and oxaliplatin with and without cetuximab in the first-line treatment of metastatic colorectal cancerCarsten Bokemeyer, Igor Bondarenko, Anatoly Makhson, et al.
Nature Biotechnology|June 29, 2002
Generation of histocompatible tissues using nuclear transplantationRobert P Lanza, Ho Yun Chung, James J Yoo, et al.
Stem Cells and Development|June 10, 2004
Identification of the adult human hemangioblastSonja Loges, Boris Fehse, Marc A Brockmann, et al.
Clinical Colorectal Cancer|July 13, 2024
Trifluridine/Tipiracil Based Chemoradiation in locally Advanced Rectal Cancer: The Phase I/II TARC TrialBenjamin Thiele, Alexander Stein, Christoph Schultheiß, et al.
Cells|February 5, 2020
Targeting CD38-Expressing Multiple Myeloma and Burkitt Lymphoma Cells In Vitro with Nanobody-Based Chimeric Antigen Receptors (Nb-CARs)Julia Hambach, Kristoffer Riecken, Sophia Cichutek, et al.
Lung Cancer (Amsterdam, Netherlands)|April 20, 2007
A phase II study of irinotecan (CPT-11) and carboplatin in patients with limited disease small cell lung cancer (SCLC)Eckart Laack, Ina Thöm, Andreas Krüll, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 20, 2008
Phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil, leucovorin plus either oxaliplatin or cisplatin: a study of the Arbeitsgemeinschaft Internistische OnkologieSalah-Eddin Al-Batran, Joerg Thomas Hartmann, Stephan Probst, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 3, 2018
Sequential Versus Combination Therapy of Metastatic Colorectal Cancer Using Fluoropyrimidines, Irinotecan, and Bevacizumab: A Randomized, Controlled Study-XELAVIRI (AIO KRK0110)Dominik Paul Modest, Ludwig Fischer von Weikersthal, Thomas Decker, et al.
Theranostics|March 21, 2020
Nanobody-based CD38-specific heavy chain antibodies induce killing of multiple myeloma and other hematological malignanciesLevin Schriewer, Kerstin Schütze, Katharina Petry, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Leukemia & Lymphoma|December 16, 2006
Downregulation of VEGF-A, STAT5 and AKT in acute myeloid leukemia blasts of patients treated with SU5416Sonja Loges, Heike Tinnefeld, Anja Metzner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2008
Fluorouracil, leucovorin, and oxaliplatin with and without cetuximab in the first-line treatment of metastatic colorectal cancerCarsten Bokemeyer, Igor Bondarenko, Anatoly Makhson, et al.
Nature Biotechnology|June 29, 2002
Generation of histocompatible tissues using nuclear transplantationRobert P Lanza, Ho Yun Chung, James J Yoo, et al.
Stem Cells and Development|June 10, 2004
Identification of the adult human hemangioblastSonja Loges, Boris Fehse, Marc A Brockmann, et al.
Clinical Colorectal Cancer|July 13, 2024
Trifluridine/Tipiracil Based Chemoradiation in locally Advanced Rectal Cancer: The Phase I/II TARC TrialBenjamin Thiele, Alexander Stein, Christoph Schultheiß, et al.
Cells|February 5, 2020
Targeting CD38-Expressing Multiple Myeloma and Burkitt Lymphoma Cells In Vitro with Nanobody-Based Chimeric Antigen Receptors (Nb-CARs)Julia Hambach, Kristoffer Riecken, Sophia Cichutek, et al.
Lung Cancer (Amsterdam, Netherlands)|April 20, 2007
A phase II study of irinotecan (CPT-11) and carboplatin in patients with limited disease small cell lung cancer (SCLC)Eckart Laack, Ina Thöm, Andreas Krüll, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 20, 2008
Phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil, leucovorin plus either oxaliplatin or cisplatin: a study of the Arbeitsgemeinschaft Internistische OnkologieSalah-Eddin Al-Batran, Joerg Thomas Hartmann, Stephan Probst, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 3, 2018
Sequential Versus Combination Therapy of Metastatic Colorectal Cancer Using Fluoropyrimidines, Irinotecan, and Bevacizumab: A Randomized, Controlled Study-XELAVIRI (AIO KRK0110)Dominik Paul Modest, Ludwig Fischer von Weikersthal, Thomas Decker, et al.
Theranostics|March 21, 2020
Nanobody-based CD38-specific heavy chain antibodies induce killing of multiple myeloma and other hematological malignanciesLevin Schriewer, Kerstin Schütze, Katharina Petry, et al.
Pageof 5